: NGS & Clinical Diagnostics

NGS & Clinical Diagnostics

23 - 25 October 2024 | London, UK
16th Annual
Next Generation Sequencing & Clinical Diagnostics Congress23 - 25 October 2024 | London, UK

An outstanding and comprehensive programme discussing key areas shaping next generation sequencing, drug development and personalised healthcare. Case studies include integration of NGS to clinical development to personalised therapies and innovative treatments.  

This Year's Event Includes...

Over 700 attendees representing internationally renowned academic institutions, research institutes and hospitals as well as global pharmaceutical organisations and leading biotech companies

Over 100 case studies, presentations, panel discussions focused on key issues such as clinical genomics, multi omic data integration, NGS applications in the clinic for diagnostics development and advanced bioinformatics tools & technologies 

Maximise your event experience with exclusive interactive programme features such as workshops, panel discussions and roundtables, tapping into the priorities & challenges of the wider sequencing & clinical genomics market  

Agenda at a Glance

Day One

  • Clinical implementation of genomic medicine 
  • Delivering personalised cancer care 
  • Holistic approaches to diagnoses 
  • Whole genome sequencing 
  • Computational methods for human genetic diversity 
  • Applications of multi-omics data for personalised medicine 
  • Large-scale multi omics data analysis  
  • Case studies from omics: proteomics, genomics, transcriptomics, epigenomics  
  • ML-driven target identification 
  • Integrating multiple datasets 
  • AI/ML toolkits for multi omics datasets 

Day Two

  • Novel NGS analysis techniques in the clinic    
  • Using transcriptomics for diagnosis of patients in the clinic (RNAseq)   
  • Long and short read sequencing in the clinic  
  • Diagnostics of rare diseases 
  • Whole genome sequencing using long & short read sequencing 
  • Novel methods, approaches, and platforms for data integration 
  • Data driven & omics-based approaches for identifying novel clinical indications 
  • Tools for analysing high-throughput sequencing data 
  • Bioinformatics and computational analysis tools for NGS data